Utilize este identificador para referenciar este registo:
https://hdl.handle.net/10316/105820
Título: | Combining Virtual Screening Protocol and In Vitro Evaluation towards the Discovery of BACE1 Inhibitors | Autor: | Coimbra, Judite R. M. Baptista, Salete Dinis, Teresa Silva, Maria M. C. Moreira, Paula I. Santos, Armanda Emanuela Castro e Salvador, Jorge A. R. |
Palavras-chave: | Alzheimer’s disease (AD); amyloid- (A ); BACE1; small bioactive molecules; virtual screening; pharmacophore modelling; molecular docking; structure- and ligand-based methods | Data: | 1-Abr-2020 | Editora: | MDPI | Projeto: | CENTRO-01-0247-FEDER-003269 (Drugs2CAD) CENTRO-01-0145-FEDER-000012 (HealthyAging2020) UIDB/04539/2020 RECI/QEQ-QFI/0168/2012 CENTRO-07-CT62-FEDER-002012 UID/QUI/00313/2019 SFRH/BD/138460/2018 University of Coimbra |
Título da revista, periódico, livro ou evento: | Biomolecules | Volume: | 10 | Número: | 4 | Resumo: | The treatment options for a patient diagnosed with Alzheimer's disease (AD) are currently limited. The cerebral accumulation of amyloid-β (Aβ) is a critical molecular event in the pathogenesis of AD. When the amyloidogenic β-secretase (BACE1) is inhibited, the production of Aβ peptide is reduced. Henceforth, the main goal of this study is the discovery of new small bioactive molecules that potentially reach the brain and inhibit BACE1. The work was conducted by a customized molecular modelling protocol, including pharmacophore-based and molecular docking-based virtual screening (VS). Structure-based (SB) and ligand-based (LB) pharmacophore models were designed to accurately screen several drug-like compound databases. The retrieved hits were subjected to molecular docking and in silico filtered to predict their ability to cross the blood-brain barrier (BBB). Additionally, 34 high-scoring compounds structurally distinct from known BACE1 inhibitors were selected for in vitro screening assay, which resulted in 13 novel hit-compounds for this relevant therapeutic target. This study disclosed new BACE1 inhibitors, proving the utility of combining computational and in vitro approaches for effectively predicting anti-BACE1 agents in the early drug discovery process. | URI: | https://hdl.handle.net/10316/105820 | ISSN: | 2218-273X | DOI: | 10.3390/biom10040535 | Direitos: | openAccess |
Aparece nas coleções: | FFUC- Artigos em Revistas Internacionais I&D CIBB - Artigos em Revistas Internacionais I&D ICBR - Artigos em Revistas Internacionais |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
biomolecules-10-00535-v2.pdf | 7.48 MB | Adobe PDF | Ver/Abrir |
Citações SCOPUSTM
16
Visto em 26/ago/2024
Citações WEB OF SCIENCETM
13
Visto em 2/ago/2024
Visualizações de página
107
Visto em 27/ago/2024
Downloads
38
Visto em 27/ago/2024
Google ScholarTM
Verificar
Altmetric
Altmetric
Este registo está protegido por Licença Creative Commons